Abstract
At the beginning of this century, Metchnikoff (1907) suggested that bacteria growing in the human large intestine affected health and longevity of the host.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahnen DJ (1991) Etiology of large bowel cancer. In: Phillips SF, Pemberton JH, Shorter RG (eds) The large intestine: physiology, pathophysiology and disease. Raven Press Ltd, New York pp 501–520
Allison C, Macfarlane GT (1988) Effect of nitrate on methane production by slurries of human faecal bacterial. J Gen Microbiol 134: 1397–1405
Alpem RJ, Dowell VR (1969) Clostridium septicum infections and malignancy. J Am Med Assoc 209: 385–389
Archer MC, Saul RL, Lee LT, Bruce WR (1981) Analysis of nitrate, nitrite and nitrosamines in human feces. In: Bruce WR, Correa P, Lipkin M, Tannenbaum SRR (eds) Banbury report no 7. Cold Spring Harbor Laboratory, New York pp 321–327
Aries VC, Crowther JS, Drasar BS, Hill MJ, Ellis FR (1971) The effect of a strict vegetarian diet on the faecal flora and faecal steroid concentration. J Pathol 103: 54–56
Aries VC, Crowther JS, Drasar BS, Hill MJ, Williams REO (1969) Bacteria and the etiology of cancer of the large bowel. Gut 10: 334–335
Bahr GM, Chedid L (1986) Immunological activites of muramyl Barker HA (1981) Amino acid degradation by anaerobic bacteria. Ann Rev Biochem 50: 23–40
Barnes WS, Mailler J, Weisburger JH (1983) In vitro binding of the food mutagen 2-amino-3methylimidazo [4,5-f] quinoline (IQ) and analogs. Carcinogenesis 6: 441–444
Bartlett JG (1983) Pseudomembranous colitis. In: Hentges DJ (ed) Human intestinal microflora in health and disease. Academic Press, London pp 448–479
Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB (1978) Antibiotic-associated pseudomembranous colitis due to toxin producing clostridia. N Engl J Med 298: 531–534
Bashir M, Kingston DGI, Carman RL, Van Tassell RL, Wilkins TD (1987) Anaerobic metabolism of 2-amino-3-methyl-3H-imidazo [4,5-f] quinoline ( IQ) by human fecal flora. Mutat Res 190: 187–190
Bennet JD, Brinkman M (1989) Treatment of ulcerative colitis by implantations of normal colonic flora. Lancet 164
Bone E, Tamm A, Hill MJ (1976) The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr 29: 1448–1454
Borriello SP (1985) Newly described clostridial diseases of the gastrointestinal tract: Clostridium perfringens enterotoxin-associated diarrhea and neutropenic enterocolitis due to Clostridium septicum. In: Borriello SP (ed) Clostridia in gastrointestinal disease. CRC Press, Boca Raton pp 223–229
Bradley HK, Wyatt GM, Bayliss CE, Hunter JO (1987) Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome. Med Microbiol 23: 29–32
Branscomb CJ, Holder CL, Kofmacher WA, Cemiglia CE, Rushing LG (1988) GC/MS characterisation of urinary metabolites of deoxyalanine succinate: identification of aglycones formed from intestinal microflora metabolism of the polar glucuronide metabolites. J High Res Chromat and Chromat Comm 11: 517–520
Bruce WR, Dion PW (1980) Studies relating to a fecal mutagen. Am J Clin Nutr 33: 2511–2512
Bruce WR, Varghese AJ, Wang S, Dion P (1979) The endogenous production of nitroso compounds in the colon and cancer at that site. In: Miller EC (ed) Naturally occurring carcinogens, mutagens and modulators of carcinogenesis. Japan Sci Press, Tokyo pp 221–228
Calmmels S, Ohshima H, Vincent P, Gounat AM, Bartsch H (1985) Screening of microorganisms for nitrosation catalysis at p117 and kinetic studies on nitrosamine formation from secondary amines by Escherichia coli strains. Carcinogenesis 6: 911–916
Carmen RJ, Van Tassel RL, Kingston DGI, Bashir M, Wilkins TD (1987) Conversion of IQ, a dietary pyrolysis carcinogen, to a direct acting mutagen by normal intestinal bacteria of humans. Mutat Res 206: 335–342
Chadwick VS (1991) Etiology of chronic ulcerative colitis and Crohn’s disease. In: Phillips SF, Pemberton JH, Shorter RG (eds) The large intestine: physiology, pathophysiology and disease. Raven Press Ltd, New York pp 445–463
Chadwick VS, Mellor DM, Myers DB (1988) Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scan J Gastroenterol 23: 121–128
Chiodini RJ, Van Kruningen HJ, Thayer WR, Merkal RS, Coutu JA (1984) Possible role of mycobacteria in inflammatory bowel disease. 1 An unclassified Mycobacterium species isolated from patients with Crohn’s disease. Dig Dis Sci 29: 1073–1079
Chung KT, Folk GE, Egan M (1978) Reduction of azo dyes by intestinal anerobes. Appl Environ Microbiol 35: 558–562
Chung KT, Folk GE, Slein MW (1975) Tryptophanase of fecal flora as a possible factor in the etiology of colon cancer. J Nat Can I ns 54: 1073–1078
Clark AG, Fischer LG, Millburn P, Smith PL, Williams RT (1969) The role of the gut flora in the enterohepatic circulation of stilboestrol in the rat. Biochem J 112: 17 P
Cohen MB, Giannella RA (1991) Bacterial infections: pathophysiology, clinical features and treatment. In: Phillips SF, Pemberton JH, Shorter RG (eds) The large intestine: physiology, pathophysiology and disease. Raven Press Ltd, New York pp 395–428
Cooperstock MS, Zedd AJ (1983) Intestinal flora of infants. In: Hentges DJ (ed) Human intestinal microflora in health and disease. Academic Press, London pp 79–99
Cummings JH (1985) Cancer of the large bowel. In: Trowell H, Burkitt D, Heaton K (eds) Dietary fibre, fibre depleted foods and disease. Academic Press, London pp 161–189
Dion P, Bruce WR (1983) Mutagenicity of different fractions of extracts of human feces. Mutat Res 119: 151–160
Donta ST, Myers MG (1982) Clostridium difficile toxin in asymptomatic neonates. J Pediatr 10: 431–434
Drasar BS, Hill MJ (1974) Human intestinal flora. Academic Press, London
Fellitti VJ (1973) Primary invasion by Clostridium sphenoides in a patient with periodic neutropenia. Calif Med 133: 76–78
Felton JS, Knize MG, Wood C, Wuebbles BJ, Really KS, Stuermer DH, Bjeldanes LF, Kimble BJ, Hatch FT (1984) Isolation and characterisation of new mutagens from fried ground beef. Carcinogenesis 5: 95–102
Finegold SM, Flora DJ, Attlebury HR, Sutter LV (1975) Fecal bacteriology of colonic polyp patients and control patients. Cancer Res 35: 3407–3417
Florin THJ, Gibson GR, Neale G, Cummings JH (1990) A role for sulfate-reducing bacteria in ulcerative colitis? Gastroenterology 98: A170
Fu PP, Cemiglia CE, Richardson KE, Heflich RII (1988) Nitroreduction of 6-nitrobenzo[alpyrene: a potential activation pathway in humans. Mutat Res 209: 123–129
Gale EF (1946) The bacterial amino acid decarboxylases. Adv Enzymol 6: 1–32
Gibson GR, Cummings JH, Macfarlane GT (1991) Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Ecol 86: 103–112
Gilmour AM (1989) Crohn’s disease. In: Whitehead R (ed) Gastrointestinal and oesophageal pathology. Churchill Livingstone, Edinburgh, p 540
Gitnick G, Collins J, Beaman B, Brooks D, Arthur M (1985) Mycobacteria in Crohn’s disease. Gastroenterology 88: A15–92
Goldin B (1986) In situ bacterial metabolism and colon mutagens. Ann Rev Microbiol 40: 367–393
Goldschmidt MC, Lockhart BM (1971) Rapid methods for determining decarboxylase activity: arginine decarboxylase. Appl Microbiol 22: 350–357
Graham DY, Markesich DC, Yoshimura HH (1987) Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology 92: 436–442
Gruter H (1985) Gas gangrene following antibiotic-associated enterocolitis in hereditary neutropenia. Arch Anat Cytol Pathol 33: 23–25
Hagopian HK, Riggs MG, Swartz LA, Ingram VM (1977) Effect of n-butyrate on DNA synthesis in chick fibroblasts and hela cells. Cell 12: 855–860
Hill MJ (1986) The possible role of bacteria in inflammatory bowel disease. Curt Con Gastroenterol 3: 10–14
Hill MJ, Drasar BS, Aries V, Crowther IS, Williams REO (1971) Bacteria and aetiology of cancer of the large bowel. Lancet 95–100
Hill MJ, Drasar BS, Williams REO, Meade TW, Cox AG, Simpson JEP, Morson BC (1975) Faecal bile acids and clostridia in patients with cancer of the large bowel. Lancet 535–538
Iyengar R, Stuele DJ, Marietta MA (1987) Macrophage synthesis of nitrite, nitrate and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci USA 84: 6397–6373
Janowitz HD, Bilotta JJ (1991) Critical evaluation of the medical therapy of inflammatory bowel disease. In: Phillips SF, Pemberton JH, Shorter RG (eds) The large intestine: physiology, paophysiology and disease. Raven Press Ltd, New York pp 475–500
Kasai HZ, Nishimura S, Wakabayashi K, Nagao M, Sugimura T (1980a) Chemical synthesis of 2-amino3-methylimidazole [4,5-f] quinoline ( IQ), a potent mutagen isolated from broiled fish. Proc Jpn Acad 56: 382–384
Kasai HZ, Yamauimi Z, Wakabayashi K, Nagao M, Sugimura T (1980b) Potent novel mutagens produced by broiling fish under normal conditions. Proc Jpn Acad 56: 278–283
Kim YS, Tsao D, Morita A, Bella A (1982) Effect of sodium butyrate and three human colorectal adenocarcinoma cell lines in culture. Falk Symp 31: 317–323
King A, Rampling A, Wright DGD, Warren RE (1984) Neutropenic enterocolitis due to Clostridium septicum infection. J Clin Pathol 37: 335–343
Kingston DGI, Van Tassel RL, Wilkins TD (1990) The fecapentaenes, potent mutagens from human feces. Chem Res Toxicol 3: 391–400
Lupton JR (1991) Dietary fiber and short chain fatty acids–implications for colon cancer: animal models. In: Cummings JH, Rombeau JL, Sakata T (eds) Short chain fatty acids: metabolism and clinical importance. Ross Laboratories Press, Columbus pp 86–90
MacDonald IA, Bussard RG, Hutchinson DM, Holdeman LV (1984) Rutin-induced ß-glucosidase activity in Streptococcus faecium VGH-1 and Streptococcus sp. strain FRP-17 isolated from human feces. Formation of the mutagen quercetin from rutin. Appl Environ Microbiol 47: 350–355
Macfarlane GT, Cummings JH, Allison C (1986) Protein degradation by human intestinal bacteria. J Gen Microbiol 132: 1647–1656
Macfarlane GT, Gibson GR, Cummings JH (1991) Extracellular and cell-associated glycosidase
activities in different regions of the human large intestine. Lett Appl Microbiol 12, 3–7
Manning BW, Campbell WL, Franklin W, Declos KB, Cemiglia CE (1988) Metabolism of 6-nitrochrysene by intestinal microflora. Appl Environ Microbiol 54: 197–203
Marcus R, Watt J (1969) Seaweeds and ulcerative colitis in laboratory animals. Lancet 489–490 Metchnikoff E ( 1907 ) The prolongation of life. Heinemann, London
Monteiro E, Fossey J, Shiner M, Drasar BS, Allison AC (1971) Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet 249–251
Moore WEC, Holdeman LV (1975) Discussion of current bacteriological investigations of the relationships between intestinal flora, diet, and colon cancer. Cancer Res 35: 3418–3420
Morotomi M, Guillem JG, LoGerfo P, Weinstein IB (1990) Production of diacylglycerol, an activator of protein kinase C, by human intestinal microflora.Cancer Res 50: 3595–3599
Newbold KM, Lord MG, Baglin TP (1987) Role of clostridial organisms in neutropenic enterocolitis. J Clin Pathol 40: 471
Onderdonk AB (1983) Role of the intestinal microflora in ulcerative colitis. In: Hentges DJ (ed) Human intestinal microflora in health and disease. Academic Press, London pp 481–493
Onderdonk AB, Bartlett MD (1979) Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr 32: 258–265
Onderdonk AB, Hermos JA, Dzink JL, Barlett JG (1978) Protective effect of metronidazole in experimental ulcerative colitis. Am J Clin Nutr 32: 1819–1825
Prasad KN (1980) Butyric acid: a small fatty acid with diverse biological functions. Life Sci 27: 1351–1358
Price AB (1977) Difficulties in the differential diagnosis of ulcerative colitis and Crohn’s disease. In: Yardley H, Morson BC (eds) The gastrointestinal tract, Williams and Wilkins, Baltimore pp 1–14
Radcliffe BC, Nance SH, Deakin FJ, Roediger WEW (1985) Nitrate and nitrite content of ileostomy effluent after a normal or high nitrate meal. Clin Invest Med 8: A94
Rafii F, Franklin W, Cemiglia CE (1990) Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora. Appl Environ Microbiol 56: 2146–2151
Renwick 1986 Gut bacteria and the metabolism of aromatic amino acids. In: Hill MJ (ed) Microbial metabolism in the digestive tract. CRC Press, Boca Raton, pp 107–122
Richardson KE, Fu PP, Cemiglia CE (1988) Metabolism of 1-, 3-, and 6-nitrobenzo[a]pyrene by intestinal microflora. J Toxicol Environ Health 23: 527–537
Roediger WEW (1992) The role of sulphur metabolism and mercapto fatty acids in the aetiology of ulcerative colitis. In: Goebell H, Ewe H, Malchow H (eds) Inflammatory bowel diseases. Progress in basic research and clinical implications, MW Press, Lancaster - in press
Rowland IR (1988) Interactions of the gut microflora and the host in toxicology. Toxicol Pathol 16: 147–153
Sartor RB, Cromartie WJ, Powell DW, Schwab JH (1985) Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 89: 587–595
Schaffer JL, Hughes S, Linaker BD, Baker RD, Tumberg LA (1984) Controlled trial of rifampicin and ethambutol in Crohn’s disease. Gut 25: 203–205
Schiffman MH, Bittennan P, Viciana AL, Schairer C, Russell L, Van Tassell RL, Wilkins TD (1988) Fecapentaenes and their precursors throughout the bowel–an autopsy study. Mutat Res 208: 9–15
Spatz M, Smith DWE, McDaniel EG, Laquer GL (1967) Role of intestinal microorganisms in determining cycasin toxicity. Prc Soc Biol Med (New York) 124: 691–697
Spoelstra SF (1977) Simple phenol and indoles in anaerobically stored piggery wastes. J Sci Food Agr 28: 415–423
Suzuki K, Mitsuoka T (1984) N-nitrosamine formation by intestinal bacteria. In: O’Neill IK, von Borstel RC, Miller CT, Long J, Bartsch H (eds) Nitroso compounds: occurrence, biological effects and relevance to human cancer. Int Agency Res Cancer, Lyon pp 275–281
Tamura G, Gold C, Ferro-Luzzi A, Ames BN (1980) Fecalase: a model for activation of dietary glycosides to mutagens by intestinal flora. Proc Natl Acad Sci (USA) 77: 4961–4965
Tedesco FJ (1976) Clindamycin-associated colitis. Review of the clinical spectrum of 47 cases. Dig Dis 21: 26–32
Thompson MH (1982) The role of diet in relation to faecal bile acid concentration and large bowel cancer. In: Malt RA, Williamson RCN (eds) Colonic carcinogenesis. MTP Press, The Hague pp 49–56
Van Tassell RL, Kingston DGI, Wilkins TD (1990) Metabolism of dietary genotoxins by the human colonic microflora: the fecapentaenes and heterocyclic amines. Mutat Res 238: 209–221
Van Tassell RL, MacDonald DK, Wilkins TD (1982a) Production of a fecal mutagen by Bacteroides spp. Infect Imm 37: 975–980
Van Tassell RL, MacDonald DK, Wilkins TD (1982b) Stimulation of mutagen production in human feces by bile and bile acids. Mutat Res 103: 233–239
Van Tassell RL, Piccariello T, Kingston DGI, Wilkins TD (1989) The precursors of fecapentaenes: purification and properties of a novel plasmologen. Lipids 24: 454–459
Vargo D, Moskovitz M, Flock MH (1980) Faecal bacterial flora in cancer of the colon. Gut 21: 701–705 Watt J, Marcus R (1971) Carrageenan induced ulceration of the large intestine in the guinea pig. Gut 12: 164–171
Whitehead R (1989) Ulcerative colitis. In: Whitehead R (ed) Gastrointestinal and oesophageal physiology, Churchill Livingstone, Edinburgh pp 522–531
Wilkins TD, Van Tassell RL (1983) Production of intestinal mutagens. In: Hentges DJ (ed) Human intestinal microflora in health and disease. Academic Press, London pp 265–288
Williams RT (1972) Toxicological implications of biotransformation by intestinal microflora. Toxicol Appl Pharm 23: 769–781
Witter JP, Balish E, Gatley SJ (1979) Distribution of nitrogen-13 from labelled nitrate and nitrite in germ-free and conventional flora rats. Appl Environ Microbiol 38: 870–878
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag London Limited
About this chapter
Cite this chapter
Gibson, G.R., Macfarlane, G.T. (1994). Intestinal Bacteria and Disease. In: Gibson, S.A.W. (eds) Human Health. Springer Series in Applied Biology. Springer, London. https://doi.org/10.1007/978-1-4471-3443-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3443-5_3
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3445-9
Online ISBN: 978-1-4471-3443-5
eBook Packages: Springer Book Archive